Skip to main content

Table 1 Patient demographics

From: Cardiovascular magnetic resonance-guided right heart catheterization in a conventional CMR environment – predictors of procedure success and duration in pulmonary artery hypertension

Characteristic Finding Range (min-max)
Age (years) 57 +/−  15 20–83
Female gender, n (%) 40 (80)  
Height (m) 1.63 (1.56–1.73) 1.46–1.95
Weight (kg) 71 +/−  16 40–105
BSA (m2) 1.8 +/− 0.2 1.4–2.4
6MWD (metres) 333 (150–440) 0–582
NT-proBNP (ng/L) 320 (110–841) 50–52,746
WHO FC, n (%)
 1 2 (4)  
 2 12 (24)  
 3 32 (64)  
 4 4 (8)  
PAH, n (%) 39 (78)  
Group 1 33 (66)  
 - Idiopathic 8  
 - CTD 23  
 - PVOD 1  
 - Portopulmonary 1  
Group 2 2 (4)  
Group 3 2 (4)  
Group 4 1 (2)  
Group 5 1 (2)  
PAH therapy, n (%)
 - Phosphodiesterase type 5 inhibitor 24 (48)  
 - Endothelin receptor antagonist 23 (46)  
 - Intravenous Epoprostenol 2 (4)  
  1. All normally distributed data are presented as mean ± standard deviation, non-parametric data are presented as median (Q1-Q3) and proportions as n (%)
  2. BSA Body surface area, CTD Connective tissue disease, NT-proBNP N-terminal pro-brain natriuretic peptide, PAH Pulmonary artery hypertension, PVOD Pulmonary veno-occlusive disease, WHO FC World Health Organisation Functional Class, 6MWD 6-min walk distance